GuidelineInternational journal of urology : official journal of the Japanese Urological Association2026
Consensus-Based Development of a Surgical Checklist for Transurethral Resection of Bladder Tumor: An Initiative of the Japanese Society of Urologic Oncology.
Guideline in International journal of urology : official journal of the Japanese Urological Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
objectiveThis study aimed to develop a nationwide, consensus-based surgical checklist to standardize transurethral resection of bladder tumor procedures and documentation.
methodsIn 2025, the Japanese Society of Urologic Oncology convened a working group of 20 bladder cancer specialist urologists to develop a national surgical checklist for transurethral resection of bladder tumors. A 12-member steering committee reviewed available evidence and proposed 30 candidate items. Using a modified Delphi approach, all members rated each item online, with consensus predefined as ≥ 75% agreement. Iterative revisions incorporating public comments and external expert input produced the final checklist.
resultsThe final checklist comprised 22 items across four sections: (i) preoperative patient and tumor information (recurrence status; upper tract urothelial carcinoma; urine cytology; clinical Tumor-Node-Metastasis staging; performance status; factors affecting surgery/anesthesia); (ii) surgical and anesthetic planning (surgical intent; resection technique; adjunctive imaging modality; additional biopsies; anesthesia method; obturator reflex prophylaxis); (iii) intraoperative tumor and resection information (tumor number; index tumor morphology; index tumor size; findings suggestive of carcinoma in situ; extent of tumor resection; detrusor muscle visible; muscle invasion suspected); and (iv) complications and adjuvant therapy (urethral stricture; intraoperative complications; immediate single instillation). An additional section provides two bladder diagrams: a male/general-use version with lower urinary tract annotations and a female-specific version, both designed for mapping tumor location, characteristics, and operative findings.
conclusionsThis checklist provides a practical framework to standardize transurethral resection of bladder tumor practice and documentation and support safe, high-quality care, warranting prospective evaluation of feasibility, adherence, and quality indicators/outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.